dc.contributor.author | Planchard, D | |
dc.contributor.author | Popat, S | |
dc.contributor.author | Kerr, K | |
dc.contributor.author | Novello, S | |
dc.contributor.author | Smit, EF | |
dc.contributor.author | Faivre-Finn, C | |
dc.contributor.author | Mok, TS | |
dc.contributor.author | Reck, M | |
dc.contributor.author | Van Schil, PE | |
dc.contributor.author | Hellmann, MD | |
dc.contributor.author | Peters, S | |
dc.contributor.author | ESMO Guidelines Committee, | |
dc.date.accessioned | 2020-06-08T14:54:17Z | |
dc.date.issued | 2018-10-01 | |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 29 Suppl 4 pp. iv192 - iv237 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3704 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdy275 | |
dc.format | Print-Electronic | |
dc.format.extent | iv192 - iv237 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | ESMO Guidelines Committee. Electronic address: [email protected] | |
dc.subject | Humans | |
dc.subject | Carcinoma, Non-Small-Cell Lung | |
dc.subject | Lung Neoplasms | |
dc.subject | Neoplasm Staging | |
dc.subject | Treatment Outcome | |
dc.subject | Molecular Diagnostic Techniques | |
dc.subject | Incidence | |
dc.subject | Risk Assessment | |
dc.subject | Risk Factors | |
dc.subject | Predictive Value of Tests | |
dc.subject | Consensus | |
dc.subject | Medical Oncology | |
dc.subject | Pathology, Clinical | |
dc.subject | Algorithms | |
dc.subject | Decision Support Techniques | |
dc.title | Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1093/annonc/mdy275 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2018-10 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology/Thoracic Oncology (hon.) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology/Thoracic Oncology (hon.) | |
pubs.publication-status | Published | |
pubs.volume | 29 Suppl 4 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Thoracic Oncology | |
dc.contributor.icrauthor | Popat, Sanjay | |